Literature DB >> 26740049

Off-pump versus on-pump coronary artery bypass grafting surgery in high-risk patients: PRAGUE-6 trial at 30 days and 1 year.

Jan Hlavicka1, Zbynek Straka1, Stepan Jelinek1, Petr Budera1, Tomas Vanek1, Marek Maly2, Petr Widimsky1.   

Abstract

AIMS: Off-pump coronary artery bypass graft surgery (OPCAB) is an established alternative to on-pump surgical revascularization. Previous studies in patients with low or intermediate risk showed no significant differences between off-pump and on-pump surgical revascularization. The aim of this study was to compare the two techniques in patients with high operative risk.
METHODS: PRAGUE-6 is a prospective randomized single-center study of 206 patients, with an additive EuroSCORE ≥ 6, scheduled for isolated coronary surgery: Group A - on-pump (n = 108) versus Group B - off-pump (n = 98). The primary outcome was a combined endpoint of all-cause deaths, stroke, myocardial infarction, or renal failure requiring new hemodialysis, within 30 days and 1 year after randomization. All data were analyzed using the "intention-to-treat" principle.
RESULTS: Early postoperative myocardial infarction was detected in 12.1% (A) vs. 4.1% (B) of patients (P = 0.048, hazard ratio 0.32, 95% CI 0.11-0.99). There was a significantly higher incidence of primary combined end-point in group A (20.6% vs. 9.2%, P = 0.028, HR 0.41, 95% CI 0.19-0.91) in the first 30 days, but not after 1 year (30.8% vs. 21.4%, P = 0.117, HR 0.65, CI 0.37-1.12).
CONCLUSION: Off-pump surgical revascularization in patients with high operative risks can significantly reduce the incidence of major postoperative complications during the first 30 days. There was no statistically significant difference in the incidence of these complications after 1 year.

Entities:  

Keywords:  cardiopulmonary bypass; high-risk patient; off-pump; revascularization

Mesh:

Year:  2016        PMID: 26740049     DOI: 10.5507/bp.2015.059

Source DB:  PubMed          Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub        ISSN: 1213-8118            Impact factor:   1.245


  6 in total

1.  Outcomes of off-pump versus on-pump coronary artery bypass graft surgery in patients with severely dilated left ventricle.

Authors:  Sen Li; Wenhui Gong; Quan Qi; Zezhe Yuan; Anqing Chen; Jun Liu; Junfeng Cai; Mi Zhou; Zhe Wang; Xiaofeng Ye; Qiang Zhao
Journal:  Ann Transl Med       Date:  2016-09

Review 2.  Off-pump coronary artery bypass grafting in high-risk patients: a review.

Authors:  Gustavo A Guida; Pierpaolo Chivasso; Daniel Fudulu; Filippo Rapetto; Christo Sedmakov; Roberto Marsico; Mustafa Zakkar; Alan J Bryan; Gianni D Angelini
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

Review 3.  Current outcomes of off-pump versus on-pump coronary artery bypass grafting: evidence from randomized controlled trials.

Authors:  Daniel Fudulu; Umberto Benedetto; Gustavo Guida Pecchinenda; Pierpaolo Chivasso; Vito Domenico Bruno; Filippo Rapetto; Alan Bryan; Gianni Davide Angelini
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

4.  A Retrospective Study of Hemodynamic Changes in Patients After Off-Pump Coronary Artery Bypass Graft Surgery Using Impedance Cardiography.

Authors:  Xinrong Niu; Qingqing Zhang; Dong Xiao; Yuanming Zhang
Journal:  Med Sci Monit       Date:  2019-05-10

5.  Prevalence and Impact of Treatment Crossover in Cardiac Surgery Randomized Trials: A Meta-Epidemiologic Study.

Authors:  Mario Gaudino; Stephen E Fremes; Marc Ruel; Antonino Di Franco; Michele Di Mauro; Joanna Chikwe; Giacomo Frati; Leonard N Girardi; David P Taggart; Giuseppe Biondi-Zoccai
Journal:  J Am Heart Assoc       Date:  2019-10-30       Impact factor: 5.501

6.  Off- Versus On-Pump Coronary Surgery and the Effect of Follow-Up Length and Surgeons' Experience: A Meta-Analysis.

Authors:  Mario Gaudino; Umberto Benedetto; Faisal Bakaeen; Mohamed Rahouma; Derrick Y Tam; Ahmed Abouarab; Antonino Di Franco; Jeremy Leonard; Adham Elmously; John D Puskas; Gianni D Angelini; Leonard N Girardi; Stephen E Fremes; David P Taggart
Journal:  J Am Heart Assoc       Date:  2018-11-06       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.